Bruker Corporation (BIT:1BRKR)
37.28
+2.93 (8.53%)
At close: May 8, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total BSI | 3.19B |
Log In |
Log In |
Log In |
Log In |
Total BSI Growth | 17.08% |
Log In |
Log In |
Log In |
Log In |
BEST | 269.20M |
Log In |
Log In |
Log In |
Log In |
BEST Growth | -7.68% |
Log In |
Log In |
Log In |
Log In |
Eliminations from | -14.00M |
Log In |
Log In |
Log In |
Log In |
Eliminations from Growth | -12.50% |
Log In |
Log In |
Log In |
Log In |
BSI Life Science | 2.08B |
Log In |
Log In |
Log In |
Log In |
BSI Life Science Growth | 18.48% |
Log In |
Log In |
Log In |
Log In |
BSI Nano | 1.11B |
Log In |
Log In |
Log In |
Log In |
BSI Nano Growth | 14.58% |
Log In |
Log In |
Log In |
Log In |
BSI BioSpin | 930.70M |
Log In |
Log In |
Log In |
Log In |
BSI BioSpin Growth | 16.19% |
Log In |
Log In |
Log In |
Log In |
BSI CALID | 1.15B |
Log In |
Log In |
Log In |
Log In |
BSI CALID Growth | 20.40% |
Log In |
Log In |
Log In |
Log In |
Capex by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total BSI Capital Expenditures |
Log In |
Log In |
Log In |
Log In |
Total BSI Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In |
BEST Capital Expenditures |
Log In |
Log In |
Log In |
Log In |
BEST Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In |
BSI Life Science Capital Expenditures |
Log In |
Log In |
Log In |
Log In |
BSI Life Science Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In |
BSI Nano Capital Expenditures |
Log In |
Log In |
Log In |
Log In |
BSI Nano Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In |
Corporate Capital Expenditures |
Log In |
Log In |
Log In |
Log In |
Corporate Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In |
BSI BioSpin Capital Expenditures |
Log In |
Log In |
Log In |
Log In |
BSI BioSpin Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In |
BSI CALID Capital Expenditures |
Log In |
Log In |
Log In |
Log In |
BSI CALID Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In |
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Corporate, Eliminations and Other Operating Income |
Log In |
Log In |
Log In |
Log In |
Corporate, Eliminations and Other Operating Income Growth |
Log In |
Log In |
Log In |
Log In |
Total BSI Operating Income |
Log In |
Log In |
Log In |
Log In |
Total BSI Operating Income Growth |
Log In |
Log In |
Log In |
Log In |
BEST Operating Income |
Log In |
Log In |
Log In |
Log In |
BEST Operating Income Growth |
Log In |
Log In |
Log In |
Log In |
BSI Life Science Operating Income |
Log In |
Log In |
Log In |
Log In |
BSI Life Science Operating Income Growth |
Log In |
Log In |
Log In |
Log In |
BSI Nano Operating Income |
Log In |
Log In |
Log In |
Log In |
BSI Nano Operating Income Growth |
Log In |
Log In |
Log In |
Log In |
BSI BioSpin Operating Income |
Log In |
Log In |
Log In |
Log In |
BSI BioSpin Operating Income Growth |
Log In |
Log In |
Log In |
Log In |
BSI CALID Operating Income |
Log In |
Log In |
Log In |
Log In |
BSI CALID Operating Income Growth |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States | 961.10M |
Log In |
Log In |
Log In |
Log In |
United States Growth | 20.53% |
Log In |
Log In |
Log In |
Log In |
Germany | - |
Log In |
Log In |
Log In |
Log In |
Germany Growth | - |
Log In |
Log In |
Log In |
Log In |
Rest of Europe | - |
Log In |
Log In |
Log In |
Log In |
Rest of Europe Growth | - |
Log In |
Log In |
Log In |
Log In |
Total Asia Pacific | 999.60M |
Log In |
Log In |
Log In |
Log In |
Total Asia Pacific Growth | 2.89% |
Log In |
Log In |
Log In |
Log In |
Other Countries | 261.40M |
Log In |
Log In |
Log In |
Log In |
Other Countries Growth | 14.50% |
Log In |
Log In |
Log In |
Log In |
China | - |
Log In |
Log In |
Log In |
Log In |
China Growth | - |
Log In |
Log In |
Log In |
Log In |
Rest of Asia Pacific | - |
Log In |
Log In |
Log In |
Log In |
Rest of Asia Pacific Growth | - |
Log In |
Log In |
Log In |
Log In |